Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Trends in Pharmacological Sciences|May 13, 2008
Antipsychotic drug action: antagonism, inverse agonism or partial agonismPhilip G StrangeTrends in Pharmacological Sciences|February 7, 2002
Mechanisms of inverse agonism at G-protein-coupled receptorsPhilip G StrangeJournal of Molecular Neuroscience : MN|July 14, 2005
Oligomers of D2 dopamine receptors: evidence from ligand bindingPhilip G StrangeCurrent Opinion in Drug Discovery & Development|February 20, 2008
Signaling mechanisms of GPCR ligandsPhilip G StrangeBritish Journal of Pharmacology|July 29, 2010
Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptorsPhilip G StrangeFEBS Letters|July 15, 2004
CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteinsAnja Mueller, Philip G StrangeBiochemical Pharmacology|May 12, 2004
Inverse agonist properties of atypical antipsychotic drugsElizabeth Akam, Philip G StrangeThe International Journal of Biochemistry & Cell Biology|November 1, 2003
The chemokine receptor, CCR5Anja Mueller, Philip G StrangeEuropean Journal of Biochemistry|January 14, 2004
Mechanisms of internalization and recycling of the chemokine receptor, CCR5Anja Mueller, Philip G StrangeBritish Journal of Pharmacology|March 1, 2005
Mechanisms of inverse agonist action at D2 dopamine receptorsDavid J Roberts, Philip G StrangePageof 4